However, this reduction is not followed by a reduction in MMP and MIP-1α levels, indicating that the reduction is either insufficient to result in down stream effects; or alternatively that ALOX-5 is not a critical determinant of MMP and MIP-1α expression in the context of human AAA. This evidence concerns the gene ALOX5 and triple-A syndrome.